Taiho Oncology, Taiho Pharmaceutical, and Araris Biotech Advance ADC Candidate ARC-02 into Phase 1 Clinical Trials Taiho Oncology, Inc., together with Taiho Pharmaceutical Co., Ltd. and Araris Biotech AG, has…
vVARDIS Secures Strategic Investment from Apollo, Reaching Unicorn Valuation vVARDIS Holding AG, a rapidly expanding dental medtech innovator focused on transforming the way tooth decay is treated, has announced a…
Sun Pharma Enters Definitive Agreement to Acquire Organon Sun Pharmaceutical Industries Limited and Organon & Co. have entered into a definitive agreement that marks one of the most significant consolidation…
Adagio Medical Reports Successful Pivotal Outcomes for vCLAS® Ventricular Ablation System Adagio Medical Holdings, Inc. has reported compelling six-month clinical outcomes from its pivotal FULCRUM-VT Investigational Device Exemption (IDE) trial,…
WuXi Biologics’ Chengdu Microbial Manufacturing Facility Reaches Structural Completion with Key Equipment Installed WuXi Biologics has reached a major construction milestone in its global manufacturing expansion strategy, announcing the structural…
Johnson & Johnson Initiates Pivotal Head-to-Head Trial of Pulsed Field Ablation in Persistent Atrial Fibrillation Johnson & Johnson has announced the initiation of a landmark clinical study aimed at advancing…
Dental Care Alliance Unveils Strategic Transaction to Bolster Financial Stability and Drive Long-Term Growth Dental Care Alliance (DCA), one of the largest dental support organizations in the United States, has…
Sunnybrook Receives $41 Million Donation to Strengthen Canada’s Global Leadership in Clinical Trials Sunnybrook Health Sciences Centre has announced a transformative $41 million philanthropic investment aimed at reshaping the future…
Genentech Collaborates with Damon Wayans and diaTribe to Raise Awareness of Diabetes-Related Vision Loss Through ‘All Eyes on DME’ Campaign Genentech, a member of the Roche Group, has introduced a…
Bristol Myers Squibb and Pfizer Partner with Mark Cuban Cost Plus Drug Company to Expand Access to Eliquis® (apixaban) The longstanding alliance between Bristol Myers Squibb and Pfizer has announced…
Arrowhead Pharmaceuticals Secures Positive CHMP Recommendation for REDEMPLO® (plozasiran) to Treat Elevated Triglycerides in Adults with Familial Chylomicronemia Syndrome in Europe Arrowhead Pharmaceuticals has taken a significant step forward in…
Correction and Replacement: Samsung Epis Holdings Announces First Quarter 2026 Financial Results Samsung Epis Holdings has released its financial results for the first quarter of fiscal year 2026, presenting a…